Shield’s FDA-approved blood test drives cancer screening growth, pricing power, and cash-flow upside. Click for this GH ...

​Guardant Health, Inc. (NASDAQ:GH) is one of the Best Russell 2000 Stocks to Buy Right Now. Wall Street has a positive ...

Guardant Health stock was near a buy point of 112.43 on Thursday.

Guardant Health, Inc. (“Guardant Health”) (Nasdaq: GH), a leading precision oncology company, today announced the commencement of an underwritten public offering of $250.0 million of shares of ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Guardant Health (GH) been one of those stocks this year? A quick glance at the ...

Guardant Health delivered extremely robust Q3 results and raised full-year guidance, with Reveal and Shield beginning to make material contributions. Guardant's therapy selection and biopharma ...

Guardant's oncology and screening businesses are expanding at a rapid pace. New partnerships should drive further gains. Guardant's third-quarter revenue soared by 39% year over year to $265.2 million ...

FDA approves Guardant Health's blood test to help identify metastatic colorectal cancer patients eligible for targeted ...

Guardant Health, Inc. (“Guardant Health”) (Nasdaq: GH), a leading precision oncology company, today announced the pricing of an upsized underwritten public offering of 3,333,333 shares of Guardant ...

Guardant's oncology and screening businesses are expanding at a rapid pace. New partnerships should drive further gains. Shares of Guardant Health (NASDAQ: GH) rocketed 28% higher on Thursday after ...